CTVA: Transforming into a global genetics platform, targeting $2B licensing and 30% margins by 2029
Vylor is transforming into a high-margin, technology-driven platform, launching 12 new crop technology platforms and expanding its licensing business to $2B by 2040. Financial targets include 3%-4% annual revenue growth, 7%-8% EBITDA growth, and 60%+ free cash flow conversion, supported by innovati…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.